Fusion Connect, a leading provider of cloud communications and managed services, today announced the appointment of Ken ...
Clinical Trials Arena on MSN
First patient dosed in Biomea Fusion’s Phase I trial of BMF-650 for obesity
In preclinical studies, BMF-650, administered once daily at 10mg/kg and 30mg/kg, reduced food intake and weight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback